What other causes could explain persistent heavy menstrual bleeding in a patient on hormonal contraception with regular periods, after autoimmune disorders and von Willebrand disease have been excluded?

Persistent Heavy Menstrual Bleeding on Hormonal Contraception: Additional Diagnostic Considerations

After excluding von Willebrand disease and autoimmune disorders, you should systematically evaluate for structural uterine pathology (polyps, adenomyosis, leiomyomas), other coagulation disorders beyond VWD, endocrine dysfunction (thyroid disease, hyperprolactinemia, PCOS), and medication interactions as the most likely remaining causes. 1

Structural Causes Requiring Imaging Evaluation

Transvaginal ultrasound should be your first-line imaging modality to identify structural abnormalities that commonly cause breakthrough bleeding despite hormonal contraception 1:

• Endometrial polyps are a frequent structural cause in premenopausal women with persistent bleeding 1
• Adenomyosis can cause heavy bleeding that may not fully respond to hormonal therapy 1, 2
• Submucosal or intramural leiomyomas (fibroids) frequently cause menorrhagia even with contraceptive use 1, 2
• Endometrial hyperplasia must be excluded, particularly if the patient has risk factors (obesity, PCOS, chronic anovulation history) 1, 2

If transvaginal ultrasound cannot adequately visualize the endometrium due to patient body habitus, uterine position, or presence of fibroids/adenomyosis, proceed to MRI with diffusion-weighted imaging sequences 1. This provides superior tissue characterization and can evaluate the endometrium even when obscured by myometrial pathology 1.

Coagulation Disorders Beyond Von Willebrand Disease

Approximately 20-30% of women with heavy menstrual bleeding have an underlying bleeding disorder, and VWD accounts for only a portion of these cases 3, 4:

• Platelet function defects occur in approximately 9% of women with HMB and may not be detected by routine coagulation screening 3
• Coagulation factor deficiencies (Factor VII, XI, XIII deficiencies) account for 27.5% of bleeding disorders in adolescents with HMB and can present similarly to VWD 5
• Thrombocytopenia (immune or otherwise) represents 20% of bleeding disorders causing HMB 5
• Mild hemophilia carrier status should be considered if there is a family history 6

Request comprehensive hemostatic workup including: complete blood count with platelet count, PT/INR, aPTT, fibrinogen, and consider platelet function testing (PFA-100 or platelet aggregation studies) if initial screening is normal but clinical suspicion remains high 3, 5.

Endocrine Dysfunction

Thyroid dysfunction causes abnormal bleeding in approximately 3% of cases and should be screened with TSH 3, 2:

• Hypothyroidism can cause menorrhagia through multiple mechanisms including anovulation and coagulation abnormalities 6, 2
• Hyperprolactinemia disrupts normal menstrual patterns and should be evaluated with serum prolactin 1, 7
• Polycystic ovary syndrome (PCOS) affects 8% of women with HMB and can cause breakthrough bleeding despite hormonal contraception 3, 2
• Uncontrolled diabetes mellitus may contribute to abnormal bleeding patterns 2

Medication Interactions and Iatrogenic Causes

Review all concurrent medications that may interfere with hormonal contraceptive efficacy or independently cause bleeding 1, 6:

• Antiepileptic drugs (phenytoin, carbamazepine, phenobarbital) induce hepatic enzymes and reduce contraceptive hormone levels 6, 2
• Antipsychotic medications can cause hyperprolactinemia and breakthrough bleeding 2
• Anticoagulants (warfarin, DOACs) may unmask underlying bleeding tendency 6
• Herbal supplements (St. John's Wort) reduce contraceptive efficacy through enzyme induction 2

Endometrial Sampling Indications

Endometrial biopsy is mandatory in the following scenarios 1, 2:

• Women ≥35 years with recurrent anovulation or persistent bleeding despite treatment 2
• Women <35 years with risk factors for endometrial cancer: obesity, PCOS, chronic anovulation, family history of Lynch syndrome or endometrial cancer 2
• Any woman with excessive bleeding unresponsive to medical therapy regardless of age 1, 2

Diagnostic Algorithm

1. Confirm adequate contraceptive compliance and dosing - suboptimal adherence is a common cause of breakthrough bleeding 1

2. Perform transvaginal ultrasound to evaluate for structural pathology (polyps, fibroids, adenomyosis) 1

3. Order comprehensive laboratory evaluation: CBC, TSH, prolactin, and extended coagulation studies including platelet function testing 3, 2, 5

4. Consider endometrial sampling if patient meets age/risk criteria outlined above 1, 2

5. If ultrasound is inadequate, proceed to pelvic MRI with diffusion-weighted imaging 1

Common Pitfalls to Avoid

Do not assume hormonal contraception has "ruled out" all causes - structural lesions and coagulation disorders frequently coexist with hormonal therapy 1, 4:

• Platelet function defects are frequently missed because routine coagulation studies (PT, aPTT) are normal; specific platelet function testing is required 3, 5
• Persistent bleeding despite treatment warrants re-evaluation even if initial workup was normal, as some conditions evolve over time 5
• Hemoglobin ≤10 g/dL should prompt aggressive investigation for bleeding disorders, even with negative VWD screening 5
• Regular periods on birth control do not exclude structural pathology - polyps and submucosal fibroids commonly cause predictable heavy bleeding 1, 2

Treatment Considerations Based on Findings

If structural pathology is identified: polypectomy, fibroidectomy, or endometrial ablation may be indicated depending on fertility desires 2

If additional coagulation disorder is found: specific hemostatic therapy (tranexamic acid, DDAVP for platelet dysfunction, or factor concentrates) may be required in addition to hormonal management 4, 5

If endocrine dysfunction is identified: treat the underlying condition (levothyroxine for hypothyroidism, dopamine agonist for hyperprolactinemia) 2

If no cause is identified after comprehensive workup: consider switching to levonorgestrel-releasing intrauterine system (LNG-IUS), which is the most effective medical treatment for menorrhagia of any cause 2